Cargando…
A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various mouse models exist to study T2D; however, few recapitulate the early β-cell defects seen in humans. We sought to develop a nongenetic mouse model of T2D that exhibits reduced first-phase insulin secr...
Autores principales: | Parilla, Jacqueline H., Willard, Joshua R., Barrow, Breanne M., Zraika, Sakeneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952555/ https://www.ncbi.nlm.nih.gov/pubmed/29854823 http://dx.doi.org/10.1155/2018/6106051 |
Ejemplares similares
-
Neprilysin Deficiency Protects Against Fat-Induced Insulin Secretory Dysfunction by Maintaining Calcium Influx
por: Zraika, Sakeneh, et al.
Publicado: (2013) -
Does diabetes risk after SARS-CoV-2 infection depend on the viral variant?
por: Rangu, Rohita, et al.
Publicado: (2022) -
Neprilysin Is Required for Angiotensin-(1–7)’s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1–2)
por: Brar, Gurkirat S., et al.
Publicado: (2017) -
Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice
por: Esser, Nathalie, et al.
Publicado: (2022) -
Development and characterisation of a rat model that exhibits both metabolic dysfunction and neurodegeneration seen in type 2 diabetes
por: Southam, Katherine, et al.
Publicado: (2022)